Ayushexcil now authorized to issue Certificates of Origin (Non-Preferential) to boost Ayush exports: Shardul Nautiyal, Mumbai ...

Sun Pharma’s phase 2 trials of SCD-044 to treat moderate to severe psoriasis and atopic dermatitis fails to meet primary endpoint: Our Bureau, Mumbai Wednesday, June 4, 2025, 11 ...

Reckitt partners with PHFI to drive transformative public health interventions: Our Bureau, Mumbai Wednesday, June 4, 2025, 11:30 Hrs [IST] Reckitt, a leading global consumer heal ...

UK MHRA approves SFL Pharmaceuticals’ aumolertinib to treat non-small cell lung cancer: United Kingdom Wednesday, June 4, 2025, 11:00 Hrs [IST] The Medicines and Healthcare prod ...

Exporters adopting heat-treated wooden pallets & crates that comply with ISPM-15 phytosanitary standards: Expert: Nandita Vijayasimha, Bengaluru Wednesday, June 4, 2025, 09:00 Hrs ...

Shardul Nautiyal, Mumbai Wednesday, June 4, 2025, 08:00 Hrs [IST] ...

FMRAI demands withdrawal of order restricting MRs from Central govt hospitals for sales promotion: Gireesh Babu, New Delhi Wednesday, June 4, 2025, 08:00 Hrs [IST] The Federation ...

Peethaambaran Kunnathoor, Chennai Wednesday, June 4, 2025, 08:00 Hrs [IST] ...

Definitely, it is an important step by the CDSCO in combating the growing menace of Anti-Microbial Resistance (AMR) in the country. The document is expected to help various stakeholders including the ...

PCI warns rejection of application if institutions fail to submit additional information: Gireesh Babu, New Delhi Wednesday, June 4, 2025, 08:00 Hrs [IST] The Pharmacy Council of ...

Our Bureau, Mumbai Tuesday, June 3, 2025, 15:40 Hrs [IST] ...

Novartis announces phase III NATALEE trial of Kisqali reduces risk of recurrence in younger patients with early breast cancer: Basel Tuesday, June 3, 2025, 18:00 Hrs [IST] Novarti ...